Pediatric Neurology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eur J Pediatr. 2020 Dec;179(12):1873-1879. doi: 10.1007/s00431-020-03764-8. Epub 2020 Aug 8.
Small for gestational age preterm are at increased risk for future metabolic syndrome. Early indication for the disrupted metabolism may be found in the perinatal period. We aimed to evaluate whether small for gestational age preterm infants are at increased risk for hypertriglyceridemia when treated with lipid emulsions, and to investigate the association between triglyceride levels and morbidity. Small for gestational age infants ≤ 34 weeks' gestation age born during 2013-2016 were matched and compared with appropriate for gestational age counterparts. Triglyceride concentration > 250 mg/dL during treatment with parenteral nutrition was considered high. The study included 71 pairs of preterm infants. Hypertriglyceridemia was documented among 22.5% of the small for gestational age infants vs. 5.6% of the appropriate for gestational age infants (p = 0.007). Mean triglyceride levels were 194.4 ± 192.3 mg/dL and 99.9 ± 82.8 mg/dL, respectively (p < 0.001). Small for gestational age was predictive of hypertriglyceridemia (OR = 6.41; 95% CI 1.8-22.9). No significant association was found between triglyceride levels and morbidities in multivariate analysis.Conclusion: Small for gestational age preterm infants receiving lipid emulsions might be at a higher risk for hypertriglyceridemia. Routine monitoring of triglyceride levels will enable identification of the necessity for a slower increase in lipid emulsion therapy. What is Known: • Moderate and very preterm infants are routinely treated with lipid emulsions. • Small for gestational age (SGA) infants may have different metabolism, as they demonstrate higher risk for metabolic syndrome. What is New: • • SGA infants had a higher mean triglyceride level and more commonly had early hypertriglyceridemia (triglycerides > 250 mg/dL) compared with appropriate for gestational age infants treated with the same intravenous lipid dose. Small for gestational age was predictive of hypertriglyceridemia. • No significant association was found between triglyceride levels and morbidities in multivariate analysis.
小于胎龄早产儿在围产期就可能存在代谢紊乱的早期迹象,未来发生代谢综合征的风险增加。我们旨在评估对于接受脂肪乳剂治疗的小于胎龄早产儿,其发生高甘油三酯血症的风险是否增加,并探讨甘油三酯水平与发病率之间的关系。2013 年至 2016 年期间出生、胎龄为 34 周及以下的小于胎龄早产儿被匹配并与适于胎龄早产儿进行比较。当接受肠外营养时,甘油三酯浓度>250mg/dL 被认为是高的。该研究共纳入 71 对早产儿。小于胎龄组高甘油三酯血症的发生率为 22.5%,而适于胎龄组为 5.6%(p=0.007)。两组的平均甘油三酯水平分别为 194.4±192.3mg/dL 和 99.9±82.8mg/dL(p<0.001)。小于胎龄是高甘油三酯血症的预测因素(OR=6.41;95%CI 1.8-22.9)。多变量分析未发现甘油三酯水平与发病率之间存在显著相关性。结论:接受脂肪乳剂治疗的小于胎龄早产儿可能发生高甘油三酯血症的风险更高。常规监测甘油三酯水平有助于确定是否需要更缓慢地增加脂肪乳剂治疗。已知:•中、极早产儿常规接受脂肪乳剂治疗。•与适于胎龄婴儿相比,小于胎龄(SGA)婴儿的代谢可能不同,因为他们发生代谢综合征的风险更高。新发现:•与接受相同静脉内脂肪剂量治疗的适于胎龄婴儿相比,SGA 婴儿的平均甘油三酯水平更高,且更常出现早期高甘油三酯血症(甘油三酯>250mg/dL)。SGA 是高甘油三酯血症的预测因素。•多变量分析未发现甘油三酯水平与发病率之间存在显著相关性。